In the last two decades, our understanding of PI3K has evolved from recognition of growth factors, G protein-coupled receptors (GPCR) and enzymatic activities associated with certain oncogene products to targets in cancer and inflammatory diseases (50). Here, PIK3CG is linked to cancer.